KDR and neoplasm: The most important angiogenic factor is vascular endothelial growth factor receptor 2, or VEGFR2; it is a type III receptor tyrosine kinase that binds to tumor-secreted vascular endothelial growth factor (VEGF) and becomes highly activated on vascular endothelial cells upon interaction [18].